R 0002/25 (Petition for review) of 29.09.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:R000225.20250929
- Date of decision
- 29 September 2025
- Case number
- R 0002/25
- Petition for review of
- T 0314/20 2023-11-16
- Application number
- 08787264.4
- IPC class
- A61P 3/06A61K 9/48A61K 31/00A61P 3/04A61K 31/70A61K 9/20A61P 3/10A61K 9/00A61K 9/14A61K 31/7034A61K 9/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- Trudell Medical International
Generics (U.K.) Limited
STADA Arzneimittel AG
Hexal AG
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. - Board
- -
- Headnote
- -
- Relevant legal provisions
- EPC2000_R_109(1)_Sent_2European Patent Convention Art 112a(1)European Patent Convention Art 112a(2)European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(4)European Patent Convention Art 113European Patent Convention R 106European Patent Convention R 107European Patent Convention R 109(2)(a)European Patent Convention R 115(1)Rules of procedure of the Enlarged Board of Appeal Art 13Rules of procedure of the Enlarged Board of Appeal Art 14(2)
- Keywords
- -
- Catchword
- -
- Cited cases
- G 0001/03G 0002/21R 0012/09R 0015/09R 0004/11R 0018/12R 0002/13R 0008/13R 0016/13R 0009/14R 0007/15R 0008/17T 0951/92T 1423/15T 0116/18T 0233/18
- Citing cases
- -
Order
For these reasons it is decided that:
The petition for review is unanimously rejected as being clearly unallowable.